Skip to main content
Go back to Resources
Safety and Immunogenicity of Ebola Virus and Marburg Virus Glycoprotein DNA Vaccines Assessed Separately and Concomitantly in Healthy Ugandan Adults: A Phase 1b, Randomised, Double-Blind, Placebo-Controlled Clinical Trial
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons >/=18 Years Old
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources